Geriatric psychiatry is a branch of psychiatry that focuses on the mental health of older adults. Aging can bring about significant physical, psychological, and emotional changes that can disrupt a person's sense of well-being. Geriatric psychiatry looks at these changes and assesses how the aging process impacts mental health in elderly individuals. Geriatric psychiatry addresses the physical, psychological, and emotional changes associated with aging. It evaluates the impact of physical illness and functional impairment on mental health, as well as the impact of social and environmental factors on mental health. Geriatric psychiatrists address a wide range of mental health issues in the elderly, including anxiety, depression, dementia, substance use disorders, and other mental health issues. They also work to develop strategies to improve the overall quality of life of older adults. Geriatric psychiatrists use a variety of treatment approaches, such as psychotherapy, medications, and case management, to treat elderly patients’ mental health issues. For those with dementia and related issues, cognitive-behavioral therapy and activities are used to help improve memory and support meaningful activities. Geriatric psychiatrists collaborate with a variety of specialists, such as primary care physicians, nurses, social workers, and neurologists, to develop comprehensive treatment plans. They also work to coordinate care and provide support to family members. Geriatric psychiatrists work to help optimize the mental and physical health of elderly individuals. They look at the unique issues that can arise during the aging process and use a variety of treatments to help support the mental health and well-being of elderly patients.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States